Research study Program year 2021 Source: CMS Open Payments

Dose finding Trial in PPP (Phase II)

Research payments

$100,738

99 payments

Through program year 2021, $100,738 in research payments was reported against Dose finding Trial in PPP (Phase II), across 99 payments, paid by Boehringer Ingelheim Pharma GmbH & Co.KG.

Paid by: Boehringer Ingelheim Pharma GmbH & Co.KG
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$1,061	15
2020	Research	$23,592	43
2019	Research	$76,086	41

Breakdown

Who paid Research payments · program years 2019–2021

Boehringer Ingelheim Pharma GmbH & Co.KG $100,738 99 payments

Who received the money Research payments · program years 2019–2021

Wallace Medcl Grp INC Organisation paid for research $7,275 3 payments
University Of Missouri Health System Organisation paid for research $5,666 11 payments
Skin Specialists PC Organisation paid for research $5,122 8 payments
Total Skin And Beauty Dermatology Center Organisation paid for research $4,839 6 payments
Advncd Medcl Rsrch Pc Organisation paid for research $4,730 5 payments
Kansas City Dermatology PA Organisation paid for research $4,727 3 payments
Washington University School Of Medicine Department Of Orthopedics Surgery Organisation paid for research $4,675 5 payments
Clinical Partners Organisation paid for research $4,398 3 payments
Bellaire Dermatology Organisation paid for research $4,365 3 payments
Virginia Clinical Research INC Organisation paid for research $4,303 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.